22Jul/13

FDA backs Astellas' Astragraf XL for kidney transplant rejection prophylaxis – The Pharma Letter

FDA backs Astellas’ Astragraf XL for kidney transplant rejection prophylaxis
The Pharma Letter
Astellas Pharma’s (TYO: 4503) Astragraf XL (tacrolimus extended-release capsules) for the prophylaxis of organ rejection in patients receiving a kidney transplant with mycophenolate mofetil (MMF) and corticosteroids, with or without basiliximab

22Jul/13

Latest Tylenol Liver Failure Lawsuit Allegations Report: Resource4thePeople … – Watch List News (press release)

Latest Tylenol Liver Failure Lawsuit Allegations Report: Resource4thePeople
Watch List News (press release)
For instance, one easy-to-follow quiz* is provided on the MedicineNet.com web site where the answer to one of the questions is that “Acetaminophen (such as Tylenol) in excess can cause liver failure that often is permanent and results in death.” The

and more »